Inogen Q4 revenue $75.9M (-14% YoY); FY net loss $102.4M, adj EBITDA -$37.8M

Inogen Inc

2023-FY EPS reported -$4.42 revenue$315,660,000

Q4 revenue $75.9M vs $88.1M YoY; full-year revenue $315.7M vs $377.2M in 2022.
Q4 GAAP net loss $26.6M vs $56.6M loss YoY; adjusted net loss $19.4M vs $13.0M loss.
Full-year GAAP net loss $102.4M vs $83.8M loss; adjusted EBITDA -$37.8M vs -$13.5M.
Cash, equivalents and marketable securities $128.5M, no debt; gross margin improved to 37.1% in Q4.
New CCO Grégoire Ramade and CFO Michael Bourque appointed; focus on Physio-Assist U.S. launch.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Inogen Inc reported the fourth quarter and the full year ended December 31, 2023 results: revenue $75.9 million; full-year 2023 revenue of $315.7 million, net income GAAP net loss for the fourth quarter of 2023 was $26.6 million compared to GAAP net loss of $56.6 million in the fourth.

Period: the fourth quarter and the full year ended December 31, 2023
Revenue: $75.9 million; full-year 2023 revenue of $315.7 million
Net income: GAAP net loss for the fourth quarter of 2023 was $26.6 million compared to GAAP net loss of $56.6 million in the fourth
Result: reported results

Exact text from the filing

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results Fourth quarter 2023 revenue of $75.9 million; full-year 2023 revenue of $315.7 million

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

Inogen Inc filing history →

Source: SEC EDGAR

accession 0000950170-24-021113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.